Medtronic
MDT
2,169 hedge funds and large institutions have $102B invested in Medtronic in 2025 Q3 according to their latest regulatory filings, with 190 funds opening new positions, 916 increasing their positions, 812 reducing their positions, and 129 closing their positions.
47% more first-time investments, than exits
New positions opened: 190 | Existing positions closed: 129
44% more call options, than puts
Call options by funds: $924M | Put options by funds: $641M
22% more funds holding in top 10
Funds holding in top 10: 32 → 39 (+7)
13% more repeat investments, than reductions
Existing positions increased: 916 | Existing positions reduced: 812
8% more capital invested
Capital invested by funds: $94.6B → $102B (+$7.91B)
1% more funds holding
Funds holding: 2,139 → 2,169 (+30)
0.71% less ownership
Funds ownership: 84.57% → 83.87% (-0.71%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
JP Morgan Chase
New York
|
+$1.57B |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$505M |
| 3 |
Barclays
London,
United Kingdom
|
+$321M |
| 4 |
Schroder Investment Management Group
London,
United Kingdom
|
+$304M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$285M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$871M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$560M |
| 3 |
Capital Research Global Investors
Los Angeles,
California
|
-$521M |
| 4 |
Pzena Investment Management
New York
|
-$269M |
| 5 |
BlackRock
New York
|
-$265M |
MDT Hedge Fund Activity: Q3 2025 in Review
2,169 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Medtronic (MDT) for Q3 2025, worth a combined $102B — up 8.4% from $94.6B a quarter earlier.
Buyers outnumbered sellers: 190 funds opened new MDT positions and 129 closed out — a net gain of 61 holders — while 916 added to existing stakes and 812 trimmed.
The largest buyer was JP Morgan Chase, adding an estimated $1.57B. The largest seller was Goldman Sachs, cutting an estimated $871M.
- 2,169 institutional investors held Medtronic (MDT) as of Q3 2025, up from 2,139 in Q2 2025.
- Funds reported $102B of Medtronic stock for Q3 2025, up 8.4% quarter-over-quarter.
- 190 funds opened new Medtronic positions in Q3 2025 and 129 closed out, a net change of +61 holders.
- The largest Medtronic buyer in Q3 2025 was JP Morgan Chase, an estimated $1.57B added.
- The largest Medtronic seller in Q3 2025 was Goldman Sachs, an estimated $871M sold.
Based on aggregated 13F filings for Q3 2025.